Aspac Ii Acquisition CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
ASPAC II Acquisition Corp. reports continued operational inactivity and net losses for Q2 2026, with its deadline to complete a business combination extended to August 5, 2027, while facing substantial doubt regarding its going concern status.
OTC.Pink
A SPAC II Acquisition Corp. reports a net loss of $72,295 for Q1 2026, with continued focus on identifying a business combination target.
OTC.Pink
A SPAC II Acquisition Corp. reports significant redemptions, Nasdaq delisting, a complete management and board overhaul, and a going concern warning as it extends its business combination deadline.
OTC.Pink
A SPAC II Acquisition Corp. reports a net loss for Q2 2025, extends its business combination deadline to August 2027, and undergoes significant board and management changes amid substantial shareholder redemptions.
OTC.Pink
A SPAC II Acquisition Corp. reported a net loss for Q1 2025, extended its business combination deadline to August 2027, and underwent significant management and auditor changes while facing substantial doubt about its ability to continue as a going concern.
OTC.Pink
10-Q: A SPAC II Acquisition Corp. Reports Q3 2024 Results Amidst Delisting and Going Concern Uncertainty
A SPAC II Acquisition Corp. reported a net loss for the third quarter of 2024 and faces significant challenges including delisting from Nasdaq and substantial doubt about its ability to continue as a going concern.
OTC.Pink
A SPAC II Acquisition Corp. reported a net income of $280,625 for the six months ended June 30, 2024, while also securing an extension to complete its business combination until August 5, 2025.
OTC.Pink
A SPAC II Acquisition Corp. reported a net income of $142,345 for the first quarter of 2024, while facing ongoing challenges related to maintaining its Nasdaq listing and securing a business combination.